Although Daskivich et al. revealed that age-related comorbidities may reduce prognostic value of PSA for prostate-related conditions,22 we could not find another study evaluating the prognostic value of PSA in COVID-19 patients. The gene discussed is PROS1; the disease is COVID-19.